组织血管支架和超临界二氧化碳技术在心血管疾病中的进步和挑战
Horng-Ta Tseng1,2,3, Yi-Wen Lin1,4, Shih-Ying Sung5
1Taipei Heart Institute, Taipei Medical University, Taipei, 11031, Taiwan.
Tissue engineering and regenerative medicine
|March 3, 2025
概括
超临界二氧化碳 (ScCO2) 技术为创建组织血管支架提供了一种生物相容和环保的方法. 这种方法对推进心血管疾病治疗和组织再生充满希望.
科学领域:
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
- 心血管工程 心血管工程
背景情况:
- 动脉样硬化需要替代性血管移植,因为自身血管的限制.
- 脱细胞化组织支架为心血管应用提供高生物相容性.
- 超临界二氧化碳 (ScCO2) 越来越多地用于脱细胞化.
研究的目的:
- 审查心血管疾病组织血管支架的当前发展情况.
- 专注于ScCO2技术在该领域的应用和挑战.
主要方法:
- 在PubMed.com上进行了全面的文献搜索.
- 搜索包括到2024年6月的相关关键字和特定术语.
主要成果:
- ScCO2是一种有效的,环保的脱细胞化剂,可保存细胞外基质 (ECM).
- ScCO2衍生的支架具有高生物相容性和降低的免疫反应,支持细胞增殖和组织再生.
- 应用包括为再生医学脱细胞化心脏门和动脉.
结论:
- ScCO2技术具有诸如低细胞毒性,成本效益和易于操纵等优势.
- 这些特性使得ScCO2成为促进心血管组织再生研究的宝贵工具.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...


